ENST00000711482.1:c.6310T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000711482.1(CACNA1H):​c.6310T>C​(p.Cys2104Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.827 in 1,530,922 control chromosomes in the GnomAD database, including 525,248 homozygotes. In-silico tool predicts a benign outcome for this variant. 5/6 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C2104Y) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.86 ( 56213 hom., cov: 36)
Exomes 𝑓: 0.82 ( 469035 hom. )

Consequence

CACNA1H
ENST00000711482.1 missense

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.557

Publications

17 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 16-1220349-T-C is Benign according to our data. Variant chr16-1220349-T-C is described in ClinVar as Benign. ClinVar VariationId is 96018.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.976 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.6417T>C p.Asp2139Asp synonymous_variant Exon 35 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000711482.1 linkc.6310T>C p.Cys2104Arg missense_variant Exon 36 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.6259T>C p.Cys2087Arg missense_variant Exon 35 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.6232T>C p.Cys2078Arg missense_variant Exon 36 of 36 ENSP00000518768.1
CACNA1HENST00000348261.11 linkc.6417T>C p.Asp2139Asp synonymous_variant Exon 35 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.6432T>C p.Asp2144Asp synonymous_variant Exon 34 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.6402T>C p.Asp2134Asp synonymous_variant Exon 34 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.6399T>C p.Asp2133Asp synonymous_variant Exon 34 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.6399T>C p.Asp2133Asp synonymous_variant Exon 35 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.6384T>C p.Asp2128Asp synonymous_variant Exon 35 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.6378T>C p.Asp2126Asp synonymous_variant Exon 35 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.6366T>C p.Asp2122Asp synonymous_variant Exon 34 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.6360T>C p.Asp2120Asp synonymous_variant Exon 34 of 34 ENSP00000518754.1
CACNA1HENST00000637236.3 linkn.*2336T>C non_coding_transcript_exon_variant Exon 34 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*1465T>C non_coding_transcript_exon_variant Exon 35 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*4235T>C non_coding_transcript_exon_variant Exon 35 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5861T>C non_coding_transcript_exon_variant Exon 33 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*1358T>C non_coding_transcript_exon_variant Exon 36 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*1276T>C non_coding_transcript_exon_variant Exon 35 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1996T>C non_coding_transcript_exon_variant Exon 36 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*1084T>C non_coding_transcript_exon_variant Exon 36 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*1051T>C non_coding_transcript_exon_variant Exon 36 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.*331T>C non_coding_transcript_exon_variant Exon 34 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.6417T>C non_coding_transcript_exon_variant Exon 35 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.6384T>C non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.*1533T>C non_coding_transcript_exon_variant Exon 35 of 35 ENSP00000518777.1
CACNA1HENST00000711483.1 linkc.*331T>C 3_prime_UTR_variant Exon 35 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.*331T>C 3_prime_UTR_variant Exon 34 of 34 ENSP00000518769.1
CACNA1HENST00000637236.3 linkn.*2336T>C 3_prime_UTR_variant Exon 34 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*1465T>C 3_prime_UTR_variant Exon 35 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*4235T>C 3_prime_UTR_variant Exon 35 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5861T>C 3_prime_UTR_variant Exon 33 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*1358T>C 3_prime_UTR_variant Exon 36 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*1276T>C 3_prime_UTR_variant Exon 35 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1996T>C 3_prime_UTR_variant Exon 36 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*1084T>C 3_prime_UTR_variant Exon 36 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*1051T>C 3_prime_UTR_variant Exon 36 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.*331T>C 3_prime_UTR_variant Exon 34 of 35 ENSP00000518773.1
CACNA1HENST00000711488.1 linkn.*1533T>C 3_prime_UTR_variant Exon 35 of 35 ENSP00000518777.1
CACNA1HENST00000621827.2 linkn.6121+296T>C intron_variant Intron 35 of 36 6 ENSP00000518766.1

Frequencies

GnomAD3 genomes
AF:
0.858
AC:
130447
AN:
152124
Hom.:
56149
Cov.:
36
show subpopulations
Gnomad AFR
AF:
0.908
Gnomad AMI
AF:
0.843
Gnomad AMR
AF:
0.860
Gnomad ASJ
AF:
0.903
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.933
Gnomad FIN
AF:
0.865
Gnomad MID
AF:
0.889
Gnomad NFE
AF:
0.806
Gnomad OTH
AF:
0.862
GnomAD2 exomes
AF:
0.858
AC:
141229
AN:
164594
AF XY:
0.856
show subpopulations
Gnomad AFR exome
AF:
0.903
Gnomad AMR exome
AF:
0.870
Gnomad ASJ exome
AF:
0.889
Gnomad EAS exome
AF:
0.999
Gnomad FIN exome
AF:
0.852
Gnomad NFE exome
AF:
0.807
Gnomad OTH exome
AF:
0.848
GnomAD4 exome
AF:
0.823
AC:
1135149
AN:
1378680
Hom.:
469035
Cov.:
73
AF XY:
0.826
AC XY:
561774
AN XY:
680500
show subpopulations
African (AFR)
AF:
0.916
AC:
26782
AN:
29242
American (AMR)
AF:
0.865
AC:
27924
AN:
32290
Ashkenazi Jewish (ASJ)
AF:
0.896
AC:
19504
AN:
21760
East Asian (EAS)
AF:
0.999
AC:
37153
AN:
37182
South Asian (SAS)
AF:
0.922
AC:
69775
AN:
75678
European-Finnish (FIN)
AF:
0.855
AC:
35503
AN:
41542
Middle Eastern (MID)
AF:
0.904
AC:
4892
AN:
5412
European-Non Finnish (NFE)
AF:
0.802
AC:
865588
AN:
1078724
Other (OTH)
AF:
0.845
AC:
48028
AN:
56850
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
12313
24625
36938
49250
61563
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20694
41388
62082
82776
103470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.858
AC:
130571
AN:
152242
Hom.:
56213
Cov.:
36
AF XY:
0.862
AC XY:
64187
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.909
AC:
37779
AN:
41582
American (AMR)
AF:
0.860
AC:
13150
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.903
AC:
3132
AN:
3468
East Asian (EAS)
AF:
0.999
AC:
5146
AN:
5152
South Asian (SAS)
AF:
0.932
AC:
4502
AN:
4828
European-Finnish (FIN)
AF:
0.865
AC:
9190
AN:
10620
Middle Eastern (MID)
AF:
0.894
AC:
261
AN:
292
European-Non Finnish (NFE)
AF:
0.806
AC:
54813
AN:
67978
Other (OTH)
AF:
0.864
AC:
1829
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
996
1993
2989
3986
4982
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
892
1784
2676
3568
4460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.834
Hom.:
16300
Bravo
AF:
0.858
Asia WGS
AF:
0.962
AC:
3340
AN:
3470

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Epilepsy, childhood absence, susceptibility to, 6 Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 28, 2017
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jul 03, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.22
DANN
Benign
0.44
PhyloP100
-0.56
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4247094; hg19: chr16-1270349; COSMIC: COSV52353255; COSMIC: COSV52353255; API